Literature DB >> 8101406

Immunoreactivity of proliferating cell nuclear antigen in salivary gland tumours: an assessment of growth potential.

L Yang1, K Hashimura, C Qin, P Shrestha, S Sumitomo, M Mori.   

Abstract

Immunoreactivity of proliferating cell nuclear antigen (PCNA) was assessed to evaluate growth potential in surgically resected tissue specimens from 70 cases of benign and malignant salivary gland tumours. Three stage streptavidin-biotin immunoperoxidase immunostaining using monoclonal antibody to PCNA showed a heterogeneity of PCNA index and distribution. In normal salivary gland specimens, PCNA was demonstrated in the nuclei of few ductal and acinar cells. In pleomorphic adenoma a multiple nodular growth pattern was observed with positive immunoreactivity restricted to the nuclei of tubulo-ductal structures. Warthin's tumour had positive nuclei in the outer cuboidal cells of epithelial component and germinal centres of lymphoid tissue. Myoepithelioma and acinic cell carcinoma showed slightly differing values and a statistically significant difference in the value of the index was observed in tumour cell aggregates of the cribiform type of adenoid cystic carcinoma and the solid undifferentiated type and between low/intermediate and high-grade mucoepidermoid tumours. PCNA is a useful marker of tumour cell proliferation; the index correlates with the grade of malignancy in salivary gland tumours.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8101406     DOI: 10.1007/bf01606457

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  24 in total

1.  Correlation of proliferative activity in breast tissue using PCNA/cyclin.

Authors:  S Battersby; T J Anderson
Journal:  Hum Pathol       Date:  1990-07       Impact factor: 3.466

2.  Inhibition of nuclear DNA synthesis by an autoantibody to proliferating cell nuclear antigen/cyclin.

Authors:  R L Wong; M E Katz; K Ogata; E M Tan; S Cohen
Journal:  Cell Immunol       Date:  1987-12       Impact factor: 4.868

3.  Prognostic value of proliferating cell nuclear antigen in gastric carcinoma.

Authors:  S Jain; M I Filipe; P A Hall; N Waseem; D P Lane; D A Levison
Journal:  J Clin Pathol       Date:  1991-08       Impact factor: 3.411

4.  Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis.

Authors:  R L Garcia; M D Coltrera; A M Gown
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

5.  Regulation of proliferating cell nuclear antigen during the cell cycle.

Authors:  G F Morris; M B Mathews
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

6.  PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables.

Authors:  E Leonardi; S Girlando; G Serio; F A Mauri; G Perrone; S Scampini; P Dalla Palma; M Barbareschi
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

7.  Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta.

Authors:  R Bravo; R Frank; P A Blundell; H Macdonald-Bravo
Journal:  Nature       Date:  1987 Apr 2-8       Impact factor: 49.962

8.  Immunohistochemical demonstration of proliferating cell nuclear antigen in glioblastomas: pronounced heterogeneity and lack of prognostic significance.

Authors:  C Figge; G Reifenberger; K T Vogeley; M Messing; N Roosen; W Wechsler
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

9.  Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters.

Authors:  M E Harper; E Glynne-Jones; L Goddard; D W Wilson; S S Matenhelia; I G Conn; W B Peeling; K Griffiths
Journal:  Prostate       Date:  1992       Impact factor: 4.104

10.  Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle.

Authors:  P Kurki; M Vanderlaan; F Dolbeare; J Gray; E M Tan
Journal:  Exp Cell Res       Date:  1986-09       Impact factor: 3.905

View more
  3 in total

1.  Prognostic value of proliferating cell nuclear antigen in parotid gland cancer.

Authors:  Markus Stenner; Ariane Demgensky; Christoph Molls; Aline Hardt; Jan C Luers; Maria Grosheva; Christian U Huebbers; Jens P Klussmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-27       Impact factor: 2.503

2.  Cell proliferation in salivary gland adenocarcinomas with myoepithelial participation. A study of 78 cases.

Authors:  I Fonseca; A Félix; J Soares
Journal:  Virchows Arch       Date:  1997-03       Impact factor: 4.064

3.  Expression of proliferating cell nuclear antigens in parathyroid glands of renal hyperparathyroidism.

Authors:  K Ohta; T Manabe; M Katagiri; T Harada
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.